BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16967489)

  • 1. Predictability of disease progression in amyotrophic lateral sclerosis.
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Muscle Nerve; 2006 Dec; 34(6):702-8. PubMed ID: 16967489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
    Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
    J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALSFRS and appel ALS scores: discordance with disease progression.
    Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
    Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of database controls in pilot or futility studies in ALS.
    Czaplinski A; Haverkamp LJ; Yen AA; Simpson EP; Lai EC; Appel SH
    Neurology; 2006 Nov; 67(10):1827-32. PubMed ID: 17130417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis: prognostic indicators of survival.
    Mandrioli J; Faglioni P; Nichelli P; Sola P
    Amyotroph Lateral Scler; 2006 Dec; 7(4):211-20. PubMed ID: 17127559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ALSFRSr predicts survival time in an ALS clinic population.
    Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
    Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
    Desport JC; Marin B; Funalot B; Preux PM; Couratier P
    Amyotroph Lateral Scler; 2008 Oct; 9(5):273-8. PubMed ID: 18720089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with survival in the National Registry of Veterans with ALS.
    Pastula DM; Coffman CJ; Allen KD; Oddone EZ; Kasarskis EJ; Lindquist JH; Morgenlander JC; Norman BB; Rozear MP; Sams LA; Sabet A; Bedlack RS
    Amyotroph Lateral Scler; 2009; 10(5-6):332-8. PubMed ID: 19922120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis.
    Beghi E; Millul A; Logroscino G; Vitelli E; Micheli A;
    Amyotroph Lateral Scler; 2008 Jun; 9(3):163-7. PubMed ID: 18574760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis: early predictors of prolonged survival.
    Czaplinski A; Yen AA; Appel SH
    J Neurol; 2006 Nov; 253(11):1428-36. PubMed ID: 16773270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
    de Carvalho M; Swash M
    Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.
    Peysson S; Vandenberghe N; Philit F; Vial C; Petitjean T; Bouhour F; Bayle JY; Broussolle E
    Eur Neurol; 2008; 59(3-4):164-71. PubMed ID: 18230874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
    Gordon PH; Cheung YK
    Neurology; 2006 Oct; 67(7):1314-5; author reply 1314-5. PubMed ID: 17030785
    [No Abstract]   [Full Text] [Related]  

  • 18. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
    Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
    Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of primary lateral sclerosis.
    Gordon PH; Cheng B; Katz IB; Pinto M; Hays AP; Mitsumoto H; Rowland LP
    Neurology; 2006 Mar; 66(5):647-53. PubMed ID: 16534101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
    Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
    J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.